Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTooru Regulatory News (TOO)

Share Price Information for Tooru (TOO)

Share Price is delayed by 15 minutes
Get Live Data
0.17    0.00 (0.00%)
Bid:
0.16
Ask:
0.18
Spread: 0.02 (12.50%)
Market Cap: £3.72m
TOO Live PriceLast checked at - London Stock Exchange

Intraday Tooru Share Chart

Director/PDMR Shareholding

6 Mar 2026 17:13

RNS Number : 7461V
Tooru PLC
06 March 2026
 

6 March 2026

 

Tooru plc

("Tooru" or the "Company")

 

Director's Dealings / PDMR Shareholding

 

Tooru, an AIM listed company focused on the branded health and wellness sector, announces that it has been informed by Scott Livingston, the Company's CEO, that between 27 February 2026 and 04 March 2026 he acquired a total of 10,160,333 (including 1,513,838 into SIPP) ordinary shares of 0.01p each (the "Ordinary Shares") in the Company at an average price of 0.2422p per Ordinary Share.

 

Following these purchases, Scott Livingston now has a direct interest in 194,053,933 Ordinary Shares, representing 8.86 per cent. of the Company's issued share capital.

 

Concert Party

 

As disclosed in the Company's circular dated 8 May 2025 for the purposes of the City Code on Takeovers and mergers (the "Takeover Code") S-Ventures plc and Scott Livingston and his close relatives, who at the time held in aggregate an interest in 35.14 per cent. of the Company's then issued share capital, were deemed to be acting in concert. 

 

As a result of the Placing, Conversion and WRAP Retail Offer the results of which were announced on 11 February 2026, the aggregated interest of the Concert Party was diluted to 32.44 per cent.

 

Pursuant to Note 11 to Rule 9.1 of the Takeover Code, following dilution of the interest of the Concert Party, and subject to certain conditions and limitations, a subsequent acquisition of an interest in further shares without incurring an obligation to make an offer under Rule 9 is permissible.

 

Scott Livingston has relied on Note 11 to Rule 9.1 dispensation when acquiring the Ordinary Shares as set out above. Following this purchase the Concert Party is interested in aggregate in 32.90 per cent. of the Company's issued share capital.

 

 

Enquiries:

 

Tooru plc

Scott Livingston, CEO

 

Tel: +44 (0) 20 3475 0230

 

Beaumont Cornish Limited (Nominated Adviser)

Roland Cornish / Asia Szusciak / Felicity Geidt

 

 Tel: +44 (0) 20 7628 3396

 

Oberon Capital (Joint Broker)

Nick Lovering / Adam Pollock / Aimee McCusker

 

Tel: +44 (0) 20 3179 5300

 

 

Fortified Securities (Joint Broker)

Guy Wheatley / Mark Wheeler

 

 Tel: +44 (0) 20 7186 9950

 

 

Shard Capital Partners LLP (Joint Broker)

Damon Heath / Erik Woolgar

 

 Tel: +44 (0) 20 7186 9950

 

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

Appendix 1

 Notification of Transactions of Director/Person Discharging Managerial Responsibility and Connected Persons

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Scott Livingston

 

2

Reason for notification

a)

Position / status

Chief Executive Officer of Tooru plc

b)

Initial notification/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tooru Plc

b)

LEI

2138005S1G2RM953YX87

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of ÂĢ0.0001

 

ISIN: GB00BKKD0862

b)

Nature of the transaction

Purchases

c)

Price(s) and volumes(s)

 

Volumes

Prices

1,310,127

 0.237p

1,998,396

 0.2495p

842,198

 0.237p

843,882

 0.237p

821,594

 0.249p

806,468

 0.2475p

835,150

 0.2395p

95,000

 0.247p

2,002,408

 0.2495p

119,587

 0.233p

100,823

 0.244p

100,906

 0.2438p

100,906

 0.2438p

98,764

 0.242p

84,124

 0.233p

d)

Aggregated information

Aggregate volume

Price(s)

 

Total 10,160,333 ORDs

Average price 0.2422p

 

e)

Date of the transaction

Between 2026-02-27 and 2026-03-04

f)

Place of the transaction

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDQLFBQXLFBBF
Date   Source Headline
8th Jun 20262:36 pmRNSDirector/PDMR Shareholding
29th May 20267:00 amRNSTermination of proposed acquisition of Mylky
18th May 20267:00 amRNSTrading Update
6th May 20264:36 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTooru agrees in principle to acquire Mylky B.V.
20th Mar 20266:14 pmRNSChange of Registered Office
20th Mar 20269:30 amRNS-RBusiness & Operational Updates
6th Mar 20265:13 pmRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSResult of WRAP Offer, Update on Fundraising & TVR
5th Feb 20265:46 pmRNSWRAP Retail Offer
5th Feb 20264:00 pmRNSFundraising, Issue of Equity, PDMR Dealings & TVR
2nd Feb 20267:00 amRNSJuvela update: OAF new listing with major retailer
8th Jan 202610:00 amRNS-RInvestor Webinar – Link to Register
6th Jan 20264:27 pmRNS-RReplacement: Investor Webinar
6th Jan 20261:01 pmRNS-RInvestor Webinar
29th Dec 20257:00 amRNSTrading and financing update, Directorate change
29th Dec 20257:00 amRNSTrading and financing update, Directorate change
10th Nov 20257:00 amRNS-RCorporate Update – Juvela and Pulsin
3rd Nov 20257:00 amRNS-RfocusIR Investor Interview
23rd Oct 20257:00 amRNSUpdate re Juvela
30th Sep 20257:00 amRNSUnaudited Interims for six months to 30 June 2025
18th Aug 202511:09 amRNSChange of Registered Office
17th Jul 20252:30 pmRNSResult of AGM
11th Jul 20258:43 amRNS-RCorporate Update - Juvela
1st Jul 20257:00 amRNSPublication of audited results of S-Ventures plc
23rd Jun 20258:25 amRNSNotice of AGM
19th Jun 20257:00 amRNSFinal Results
5th Jun 20257:00 amRNS-RLaunch of OAF by Juvela
29th May 20253:15 pmRNSHolding(s) in Company
29th May 20259:16 amRNSReplacement Completion, AIM Admission, AIM Rule 26
29th May 20258:00 amRNSReadmission - Riverfort Global Opportunities Plc
29th May 20257:00 amRNSCompletion, AIM Admission, AIM Rule 26 and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.